Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Padil: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Padil - General Information

A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem]

 

Pharmacology of Padil

Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.

 

Padil for patients

Glycine supplementation should be avoided by pregnant women and nursing mothers. Because of some conversion of glycine to ammonia, those with hepatic impairment should avoid glycine supplementation unless prescribed. Interactions: Antispastic drugs. Theoretically, supplemental glycine might have additive effects when used in conjunction with baclofen, diazepam, dantrolene sodium and tizanidine.

 

Padil Interactions

 

Padil Contraindications

Glycine supplementation is contraindicated in those hypersensitive to any component of the preparation. It is also contraindicated in those who are anuric (some glycine gets converted to ammonia).

 

Additional information about Padil

Padil Indication

Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.

Mechanism Of Action
In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia.
Generic Name
Glycine
Synonyms
2-Aminoacetic acid; Aminoacetic acid; Aminoethanoic acid; Gly
Drug Category
Dietary supplement; Micronutrient; Non-Essential Amino Acids
Drug Type
Small Molecule; Nutraceutical; Approved
Other Brand Names containing Glycine
Aciport; Glicoamin; Glycocoll; Glycolixir; Glycosthene; Gyn-Hydralin; Padil;
Absorption
Absorbed from the small intestine via an active transport mechanism.
Toxicity (Overdose)
ORL-RAT LD50 7930 mg/kg, SCU-RAT LD50 5200 mg/kg, IVN-RAT LD50 2600 mg/kg, ORL-MUS LD50 4920 mg/kg; Doses of 1 gram daily are very well tolerated. Mild gastrointestinal symptoms are infrequently noted. In one study doses of 90 grams daily were also well tole.
Biotransformation
Hepatic
Dosage Forms of Padil
Liquid Irrigation
Chemical IUPAC Name
2-aminoacetic acid
Chemical Formula
C2H5NO2
Organisms Affected
Humans and other mammals